Search Results 361-370 of 18617 for Appendix
Confirmed presence of somatostatin receptors on all target lesions (for target/non-target/measurable lesions definition see §Appendix 2, Section 1 and 2 ...
... Appendix cancer, Gastrointestinal stromal tumor, Enlarged spleen, Stage 4 colorectal cancer, Recurrent cancer, Duodenal cancer, Bile duct injury, Bile duct ...
... Appendix cancer..., Neuroendocrine tumor, Gastrointestinal stromal tumor, Colon adenocarcinoma, IPMN. Show more areas of focus for Nabil Wasif, M.D. ...
Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≤ 1 (see APPENDIX 1). Adequate hematological, renal, metabolic and hepatic function ...
... (Appendix 1) from Screening to 90 days following the last study drug administration. Polyneuropathy Disability (PND) Score ≤IIIB (Appendix 5). NIS ≥5 and ...
... Appendix cancer, Neuroendocrine tumor, Gastrointestinal stromal tumor, Stage 4 colorectal cancer, Peritoneal carcinomatosis, Small bowel cancer ...
... Appendix 5, during the intervention period and for at least 28 days after the last dose of study intervention. Note: The investigator should evaluate the ...
... Appendix cancer, Liver cyst, Bile duct cyst, Bile duct injury, Duodenal cancer, Stage 4 colorectal cancer, Liver tumor, Liver hemangioma, Polycystic liver ...
Pedersen, M.D.. Oncologist. Rochester, MN. Areas of focus: Chemotherapy for colon cancer, Colon cancer, Anal cancer, Rectal cancer, Appendix cancer, Young-onset ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.